Cite
HARVARD Citation
Wong, A. et al. (2017). Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death‐1 monoclonal antibodies for advanced melanoma. Asia-Pacific journal of clinical oncology. 13 (6), pp. 385-390. [Online].